Background: Differentiation between primary (PLS) and amyotrophic lateral sclerosis (ALS) entails relevant consequences for prognosis and management but is mostly unreliable at early stages. The objectives of the study are: i) to determine the features at onset that could help to differentiate between PLS and ALS; ii) to evaluate the diagnostic performance of an integrated serum biomarker panel; iii) to identify the prognostic factors for patients presenting with an upper motor neuron (UMN)-syndrome. Methods: We selected and retrospectively analyzed the clinical data of patients presenting with UMN-syndrome. At the first evaluation, when available, serum biomarkers were measured using ultrasensitive single molecule array. Results: Study population included 55 PLS and 50 ALS patients. PLS patients presented a longer time to first neurological evaluation (PLS: 35.0 months, IQR: 17.0-38.0; ALS: 12.5 months, IQR: 7.0-21.3; p<0.01) and lower levels of neurofilament light chain (NfL) (PLS: 81.8 pg/mL, IQR: 38.4-111.1; ALS: 155.9 pg/mL, IQR: 85.1-366.4; p=0.01). Two PLS and three ALS patients carried the C9orf72 expansion. NfL resulted an independent predictor of final diagnosis (OR: 1.01, 95%CI: 1.00-1.02; p=0.04) and an independent prognostic factor (HR: 1.01, 95%CI: 1.00-1.01; p<0.01). Conclusions: NfL might help to differentiate PLS from ALS patients and to predict prognosis in patients with an UMN-syndrome.

Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome / Schito, Paride; Russo, Tommaso; Domi, Teuta; Mandelli, Alessandra; Pozzi, Laura; Del Carro, Ubaldo; Carrera, Paola; Agosta, Federica; Quattrini, Angelo; Furlan, Roberto; Filippi, Massimo; Riva, Nilo. - In: NEUROLOGY. - ISSN 0028-3878. - 101:8(2023), pp. 352-356. [10.1212/WNL.0000000000207223]

Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome

Schito, Paride
Primo
;
Russo, Tommaso
Secondo
;
Agosta, Federica;Furlan, Roberto;Filippi, Massimo
Penultimo
;
2023-01-01

Abstract

Background: Differentiation between primary (PLS) and amyotrophic lateral sclerosis (ALS) entails relevant consequences for prognosis and management but is mostly unreliable at early stages. The objectives of the study are: i) to determine the features at onset that could help to differentiate between PLS and ALS; ii) to evaluate the diagnostic performance of an integrated serum biomarker panel; iii) to identify the prognostic factors for patients presenting with an upper motor neuron (UMN)-syndrome. Methods: We selected and retrospectively analyzed the clinical data of patients presenting with UMN-syndrome. At the first evaluation, when available, serum biomarkers were measured using ultrasensitive single molecule array. Results: Study population included 55 PLS and 50 ALS patients. PLS patients presented a longer time to first neurological evaluation (PLS: 35.0 months, IQR: 17.0-38.0; ALS: 12.5 months, IQR: 7.0-21.3; p<0.01) and lower levels of neurofilament light chain (NfL) (PLS: 81.8 pg/mL, IQR: 38.4-111.1; ALS: 155.9 pg/mL, IQR: 85.1-366.4; p=0.01). Two PLS and three ALS patients carried the C9orf72 expansion. NfL resulted an independent predictor of final diagnosis (OR: 1.01, 95%CI: 1.00-1.02; p=0.04) and an independent prognostic factor (HR: 1.01, 95%CI: 1.00-1.01; p<0.01). Conclusions: NfL might help to differentiate PLS from ALS patients and to predict prognosis in patients with an UMN-syndrome.
2023
primary lateral sclerosis (PLS)
amyotrophic lateral sclerosis (ALS)
upper motor neuron (UMN) syndrome
neurofilament light chain (NfL)
File in questo prodotto:
File Dimensione Formato  
Neurology 101_352.pdf

solo gestori archivio

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Copyright dell'editore
Dimensione 237.81 kB
Formato Adobe PDF
237.81 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/140938
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact